Measuring relative acetylcholine receptor agonist binding by selective proton nuclear magnetic resonance relaxation experiments  by Behling, R.W. et al.
MEASURING RELATIVE ACETYLCHOLINE RECEPTOR
AGONIST BINDING BY SELECTIVE PROTON NUCLEAR
MAGNETIC RESONANCE RELAXATION EXPERIMENTS
RONALD W. BEHLING, TETSUO YAMANE, GIL NAVON, MICHAEL J. SAMMON,
AND LYNN W. JELINSKI
AT& T Bell Laboratories, Murray Hill, New Jersey 07974
ABSTRACT A method is presented that uses selective proton Nuclear Magnetic Resonance (NMR) relaxation
measurements of nicotine in the presence of the acetylcholine receptor to obtain relative binding constants for
acetylcholine, carbamylcholine, and muscarine. For receptors from Torpedo californica the results show that (a) the
binding constants are in the order acetylcholine > nicotine > carbamylcholine > muscarine; (b) selective NMR
measurements provide a rapid and direct method for monitoring both the specific and nonspecific binding of agonists to
these receptors and to the lipid; (c) a-bungarotoxin can be used to distinguish between specific and nonspecific binding
to the receptor; (d) the receptor-substrate interaction causes a large change in the selective relaxation time of the
agonists even at concentrations OOx > that of the receptor. This last observation means that these measurements
provide a rapid method to monitor drug binding when only small amounts of receptor are available. Furthermore, the
binding strategies presented here may be useful for the NMR determination of the conformation of the ligand in its
bound state.
INTRODUCTION
The nicotinic acetylcholine receptor (AChR) is perhaps
the best characterized receptor of a neurotransmitter,
(1-18) but there remain many unanswered questions about
the molecular level interactions between the receptor and
its agonists. In particular, it is important to be able to
distinguish between specific and nonspecific agonist bind-
ing; to be able to assess the importance of interaction
between the ligand and the lipid; to have strategies to
determine the conformation of the bound agonist; and
finally, to have a simple, rapid, and reliable technique to
measure agonist binding constants. These questions are
well-suited for Nuclear Magnetic Resonance (NMR)
spectroscopic investigation, and this manuscript describes
results along these lines.
The method presented here is to monitor ligand binding
to large receptor molecules by measuring selective spin-
lattice relaxation times (TI) of protons on the ligand. The
physical picture is one where many small molecules bind
and unbind to the receptor and bring back into solution
information about their bound state. This information is
then read out by selective T1 measurements on the small
molecules. In this paper we show (a) that selective T,
measurements are a very sensitive measure of ligand
binding to the acetylcholine receptor, (b) that specific and
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nonspecific binding effects can be distinguished, and (c)
that chemical amplification can be obtained by monitoring
the on-off binding of many ligand molecules to a low
concentration of receptor molecules.
MATERIALS AND METHODS
Treatment of the Data
We have a situation where a ligand, L, is binding to a receptor molecule,
R, and the total ligand concentration is in large excess compared with the
receptor concentration. This means that the total amount of ligand which
is in the bound state is small. In this case, the spin-lattice relaxation of the
protons on the ligand is described by: (19, 20)
1 1 f
Tl obs T, free T, bound + Tbound (1 )
where T10,o is the observed spin-lattice relaxation time, Tlf and Tlbon,d
are the spin-lattice relaxation times of the free and bound ligand,
respectively, and Tboh,d is the lifetime of the bound state. The T,'s can be
either nonselective or selective spin-lattice relaxation times. (21, 22) The
main difference between the selective and nonselective relaxation rates is
the frequency independent term, rc, in the selective rate. (23, 24) This
means that in the regime of slow motions (large rc) the selective relaxation
rate will be more sensitive that the nonselective relaxation rate. Conse-
quently, selective relaxation times were used to obtain 1 / TI0ob
Ideally, the value of T, f,,e is the relaxation time observed for the ligand
alone in aqueous solution. Biologically relevant systems, however, often
exhibit nonspecific binding as well as specific ligand binding. The proper
value of T,f is therefore the relaxation time of the ligand observed when
the specific binding has been completely blocked. The difference between
this T, f, and the relaxation measured for the ligand alone in solution is a
direct result of the nonspecific ligand binding in the biological system. In
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this study, T1f,, was measured in ligand-receptor solution after adding
a-bungarotoxin to block the specific binding site on the AChR protein.
The fraction of the ligand in the bound state, f, is [RL]/[L]. where
[RL] is the concentration of the ligand/receptor complex, and [L] is the
total ligand concentration. The dissociation constant, KD, for the reaction
is [R] [L]/[RL], and it follows from Eq. 1 that the spin-lattice relaxation
in this system is described by (25)
[R]Ip = [L]o(Tlbound + Tbound) + KD[Tlbound + Tbound], (2)
where [R]0 is the total concentration of receptor binding sites and T,p is
defined as [(l/T10b) - (1/Tf,,)]-. A plot of [R],T1pversus total ligand
concentration, [L]O, has a slope of (Tlb.,w + rbwd), and KD can be
determined from the intercept.
Once the KD and (T b,,w +Trdw) are known for one ligand, the binding
constants of other ligands can be quickly determined by measuring the
relaxation rate of the previously characterized ligand as a function of
competing ligand concentration. The relaxation behavior of the known
ligand as a function of competitive inhibitor concentration is described as
[RI]OTp = [I]o [(Tl bound + Tbound) KD
+ (Tlbound + Tbound)[KD + [L]O], (3)
where [I]O is the total concentration of the competing ligand and K1 is its
dissociation constant. A plot of [R]OT,p versus [I]O has a slope of
(Tlbouw + Tu) (KD/KI). Since (Tlbo,,d + Tbow) was previously deter-
mined (Eq. 2), the slope of Eq. 3 provides directly the ratio of (KD/KI).
Note the relative binding strengths for various ligands can be deter-
mined even when KD or [R]o are unknown if the relative [R]I is known
from measurement to measurement. The ratios of dissociation constants
for three or more compounds can easily be determined from the slope of
Eq. 3.
Freeze-Fracture
Freeze-fracture experiments were obtained by the jet-freeze, double
replica technique. (26) Approximately 0.1-0.5 ,ul of sample was trapped
between two thin copper freeze-fracture planchettes (Balzers; Hudson,
NH) to form a 10-50 ,um thick layer. The sample sandwiches were
rapidly frozen (>1 5,000GC/s) in the opposing, high velocity jets of liquid
propane at -1800C in a Balzers Cryojet 020 apparatus. The frozen
sample sandwiches were transferred to a fracture table and loaded into
the vacuum chamber of a Balzers 400 freeze-etch device. The fracture
table was opened to separate the copper platelets and to fracture the
sample under vacuum (10-8 torr) at - 1700C. The fracture surfaces were
replicated by evaporating a 15 A platinum layer into the sample at a 450
angle, followed by - 150 A of carbon evaporated at normal incidence to
provide support. These replicas were observed using a JEOL IOOCX
electron microscope with an accelerating voltage of 80 kV. Two samples
containing receptor plus a control sample of asolectin were observed by
this technique.
Isolation and Purification of Acetylcholine
Receptors and Reconstitution into Vesicles
Acetylcholine receptors were isolated from the electroplax organs of
freshly-killed Torpedo californica obtained from Pacific Biomarine in
Venice, California. They were purified and reconstituted into asolectin
vesicles according to the procedure described by Huganir and Racker
(27). Slight changes were necessary because the presence of excess free
asolectin vesicles interferes with (a) the protein determination by the dye
binding method of Schaffner and Weissman; (28) (b) the a-bungarotoxin
assay described by Ochoa et al.; (7) and (c) it broadens theNMR spectra.
The amount of free asolectin, and therefore these undesirable side effects,
were minimized by eluting the receptors from the affinity column with
carbamylcholine without asolectin in the elution buffer.
Crude Acetylcholine Receptors. The electroplax organs
were minced and added to an equal volume of pH 7.4 2X homogenization
buffer (40 mM Na2PO4, 20 mM EGTA, 10 mM EDTA, 10 mM
dithiothreitol, 20 mM benzamidine, 20 gg/ml leupeptin, 20 gg/ml
antipain, and 20 U/ml trasylol (aprotinin)). Pepstatin (10 ,ug/ml),
chymostatin (20 Ag/ml), and phenylmethylsulfonyl fluoride (0.1 mM)
were added during the first homogenization (Waring blender using eight
low speed pulses of 15 s duration, each one separated by one min
intervals). The homogenate was centrifuged for 10 min at 6,500 rpm
(6,870 g) and poured through several layers of cheese cloth. The pellets
were suspended in an equal volume of IX homogenization buffer (2X
buffer diluted), recentrifuged, and the supernatant collected as before.
The combined supernatants were centrifuged for 2 to 3 h at 13 K rpm
(20,200 g). The supernatants were then discarded and the pellets were
resuspended by adding 10 ml of the IX homogenization buffer to each
tube. Protein concentrations (A280, where an absorbence of 1.0 corre-
sponds to a value of 0.6 mg protein/ml [7]) were determined on these
crude membrane preparations, and the samples were stored frozen in
liquid nitrogen until needed for further purification.
Purified Acetylcholine Receptors. The frozen membranes
were thawed and brought to a final protein concentration of 2.5 mg/ml in
the pH 7.4 purification buffer (20 mM tris-HCI, 100 mM NaCl, 50 mM
KC1, 1 mM EDTA, 2 mM EGTA, 10 U/ml trasylol (aprotinin), 10
yg/ml leupeptin, 10 gg/ml antipain, 5 mM 2-mercaptoethanol). To this
solution, stirring on ice, was added sodium cholate (previously recrystal-
lized from 70% ethanol (8)) to a final cholate concentration of 1%. This
solution was stirred on ice for 30 min and then centrifuged for 30 min at
35 K rpm using the Ti 45 rotor (96,000 g). The supernatant was
combined with the affinity resin (see following section for preparation of
the affinity resin) in a supernatant:resin volume ratio of 20:1 and stirred
for 2-3 h at 40C.
After the resin had settled the excess solution was decanted off and the
resin was poured into a column, and the column was eluted with 150 ml of
the wash buffer (see below) at a fast rate. The protein was eluted from the
resin with 50 ml of wash buffer which was 20 mM in carbamyl choline
and collected in 1 ml fractions. Fractions were pooled according to their
A2M, and forNMR samples, the pooled protein was vacuum concentrated
down to 1-2 ml total volume. It was then dialyzed against three changes
of dialysis buffer (20 mM tris-HCl, pH 7.4, 1 mM EGTA, 5 mM
dithiothreitol, and 0.4% cholate). A fourth dialysis was performed against
D20-containing dialysis buffer. For NMR samples, the pooled fractions
after affinity chromatography were vacuum concentrated to 1-2 ml and
dialyzed against three changes of dialysis buffer (20 nM phosphate, pH
7.4, 1 mM EDTA, 5 mM DTT, and 0.4% cholate), followed by three
more dialyses against the same buffer prepared with D20.
TheNMR samples were stable for several days at 230C, and for longer
periods at 40C. Freezing the asolectin-containing sample destroyed the
AChR's ability to bind nicotine. The stability (binding activity) of a
preparation was monitored before and after long NMR runs by its
selective T,.
Preparation of the Affinity Resin. Bromoacetylcholine bro-
mide synthesis and the affinity resin preparation were carried out
according to Damle et al. (29), and cholate was purified according to
Kagawa and Racker (30).
Toxin Binding Assays. Toxin binding assays were per-
formed according to the procedure described by Fong and McNamee. (6)
We find, as have Ochoa et al. (7) and others, (31) that binding site
determinations in asolectin are not reliable, and we have estimated our
a-bungarotoxin binding site concentrations based on 8 nmol/mg protein.
(7) The effective receptor concentrations for ligand binding may be as
much as 20% lower due to the presence of multilamellar structures (See
Results and Discussion section).
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Proton NMR Relaxation Rate
Measurements
All spin-lattice relaxation rates were measured on anAM series 360 MHz
wide-bore spectrometer (Bruker Instruments, Inc., Manning Park, Biller-
ica, MA) with an Aspect 3000 data system. The sample temperature was
maintained at 22 ± 1°C by passing cooled or heated nitrogen gas over the
sample. Nonselective T,'s were measured with the standard inversion-
recovery pulse sequence. The 900 pulse width was usually 9.25 /is.
Generally 10 r values were taken ranging from 0.2 TX to 2 T,. (32)
Sixteen scans provided excellent signal to noise ratio. Selective T,'s were
measured with the inversion-recovery experiment where the desired
resonance was inverted with a 10 ms pulse from the decoupler. The
reported T, values are those determined by a three-parameter fit using the
Bruker software. The relaxation data were always single-exponential over
the entire range of r values.
Nicotine Binding Constant Measurement. Nicotine was
added in increments to solutions that typically contained from 7 to 12
mg/ml of protein in D20. Selective T, values were meausred at each
nicotine concentration.
Competitive Ligand Titrations. The NMR samples were
typically 60 to 100I M in receptor binding sites, and had starting nicotine
concentrations of 3 mM. Titrations were performed by repeatedly adding
a solution of the competing ligand to the existing NMR sample. The T1f"e
value was determined as the last step by adding a three to four-fold excess
of a-bungarotoxin to the NMR sample. The acetylcholine esterase
activity of the protein preparation was inhibited in all titrations by adding
diisopropyl fluorophosphate (Aldrich).
RESULTS AND DISCUSSION
Characterization of the
Asolectin/Acetylcholine Preparation used
for NMR Studies
Freeze fracture replicas were used to characterize the
general morphology of the receptor preparation. The pho-
tographs in Fig. 1 show that the samples contain primarily
vesicles ranging from <0.02 to 0.2 ,um in diameter. Some
large multilamellar vesicles are also present (see Fig. 1 b).
The protein (the pocked small structures, as confirmed by
examining a vesicle preparation without protein) in these
multilamellar vesicles (Fig. 1 b) is encased within several
layers of lipid bilayer. The presence of such structures may
partially explain the well-known difficulties of '251I-labeled
a-bungarotoxin binding assays, (7, 31) since a small pro-
tein such as a-bungarotoxin (74 amino acids) may not
diffuse well through the multilamellar structures to protein
entrained on the inner layers. It appears that -1% of the
vesicles are large multilamellar vesicles which may contain
up to 20% of the total AChR in the sample.
Characterization of Acetylcholine Esterase
Activity of the Receptor Preparation
It is well-known that these receptor preparations contain
residual acetylcholine esterase activity because the affinity
column purification step also selects for acetylcholine
esterase. The esterase activity from this purification
scheme was measured by NMR at a low receptor concen-
tration (5 ,uM in binding sites) by monitoring the intensity
of the acetylcholine tetramethylammonium resonance
(2.19 ppm) and the intensity of the growing acetate peak
(1.93 ppm) as a function of time at 230C. The sum of these
peak intensities remained constant, as expected. The
hydrolysis monitored by NMR is a zero order reaction
(k = 0.084 ± 0.001 min-').
Adding diisopropyl fluorophosphate to the AChR/
asolectin preparation completely inhibited acetylcholine
esterase activity as measured by NMR experiments. A
small amount of white precipitate formed when the diiso-
propyl fluorophosphate (1 ,l) was added to one to 2 ml of
the AChR/asolectin solution, but NMR relaxation mea-
surements show that nicotine binding was unaffected.
General Characterization of the NMR
Spectrum of Nicotine plus the
Receptor/Asolectin Preparation
Fig. 2 shows a proton NMR spectrum obtained for 3 mM
nicotine in the asolectin/cholate solution containing -20
,gM of receptor binding sites. The agonist, nicotine:
HB
Hc
HA N A' CH3
is particularly attractive for competitive ligand binding
NMR measurements because it has three main resonances
(HA and HA,, HB, and HC, seen from left to right on the
insert in Fig. 2) that are shifted several ppm downfield to a
region clear of the other resonances. Although well-
resolved in D20 solution, the nicotine HA and HA, are not
resolved in the asolectin/protein preparation used in these
experiments. Fig. 3 shows typical selective relaxation data
for the HB proton of nicotine.
The data in Table I illustrate the effect of asolectin,
AChR, and competing ligands on the relaxation of the
nicotine protons. In D20, the nicotine HB relaxation times
are between 3 and 4 s. The nicotine HB relaxation time
observed when asolectin vesicles are present at a concentra-
tion similar to that present in the titration experiments is
considerably shorter than the relaxation time in D20. This
suggests a large amount of nicotine binding to the lipid
vesicles, which is not surprising since the positively charged
nicotine can interact strongly with the charged lipid head
groups. This binding is expected to be nonspecific, and the
exchange rate is probably in the fast exchange limit
(TI bound »> Tbound).
Large changes occur in the selective relaxation times of
the nicotine HB proton in the presence of the AChR (Table
I, third row). Similar changes were observed for the HA,A
and HC protons (data not shown). These results suggest
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FIGURE 1 Freeze-fracture replicas of a diluted receptor preparation used for NMR studies; (a) representative field; (b) illustration of
multilamellar vesicle in preparation. Arrows indicate platinum shadow direction.
TABLE I
DATA SHOWING EFFECT OF RECEPTOR ON
RELAXATION TIMES* (s)
Nicotine (10 mM) in D20 3.1 ± 0.3 3.6 ± 0.3
Nicotine (10 mM) plus asolectin 1.97 ± 0.02 1.69 ± 0.05
Nicotine (3 mM) plus asolectin/AChRl 0.36 ± 0.02
Addition of carbamyicholine
4.5 mM 0.43 ± 0.03
13mM 0.54 ± 0.01
19 mm 0.70 ± 0.06
Addition of a-bungarotoxin 1.37 ± 0.03
*results are for the nicotine HB proton.
¶55 ,gM in binding sites.
9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0
PPM FROM TMS
FIGURE 2 Proton NMR spectrum of the AChR/asolectin preparation
containing 3 mM nicotine and 10 !LM AChR. The major peaks are
labeled on the spectrum.
that the average correlation time of the nicotine molecule
changes considerably in the presence of the protein, likely
as a result of both specific binding (i.e., to the acetyicholine
binding site) and nonspecific binding (i.e., adsorption to or
binding with other sites on the protein).
Adding a ligand that competes for binding at the AChR
binding site, e.g., carbamylcholine, displaces nicotine from
the binding site and thereby changes the observed nicotine
relaxation times because the fraction of nicotine bound is
changed (Eq. 1, Table I). The observed selective T,
increases because the contribution from Tl bund decreases
as the fraction of nicotine bound decreases. Finally, adding
a-bungarotoxin completely blocks the specific binding of
nicotine to the AChR. The measured relaxation time is the
T,f, for nicotine in this solution. Note that the selective T,
with a-bungarotoxin is similar to the selective T1 when only
asolectin is present. The difference between these values is
attributed to a small amount of nonspecific binding of
nicotine to the AChR.
Measurement of (TIbo,unld + Tbound) for Nico-
tine. Fig. 4 shows a plot of [R]0 Tlp versus nicotine
concentration for data taken from multiple measurements
on two different AChR/asolectin preparations, showing
the typical scatter in the data. These data are for the HB
proton of nicotine. The relaxation times of the Hc and HA,A'
protons were also examined and found to give similar
results (data not shown). The data are linear over a wide
range of nicotine concentrations and are reproducible from
T1 SEL OF NICOTINE HB DURING NICOTINE TITRATION
0.00014
(fl 0.00010
0
a. 0.00006
0.00002
0.0
0.0 0.002 0.004 0.006 0.008
[NICOTINE] (MOLAR)
0.010 0.012
i I I9.0o 8.0 7.0
FIGURE 3 Representative selective inversion recovery data for the HB
proton of nicotine in the AChR/asolectin preparation. From left to right,
the peaks are assigned to nicotine protons HA and HA', HB, and H0.
FIGURE 4 Plot of nicotine concentration versus [R]0 Tlp for multiple
measurements on two different AChR/asolectin preparations (circles
and squares) at 230C. The HB proton of nicotine was used for all
relaxation measurements. The data show the typical scatter in the
selective T1 measurements; error bars were determined by standard
methods involving propagation of errors. (41)
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preparation to preparation. The averaged results from two
titrations are shown in Table II (first row).
Competitive Titrations for the Receptor Binding
Site. Table I provides illustrative raw data for the com-
petitive titrations; Fig. 5 shows the competitive data plotted
for one acetylcholine and for one carbamylcholine titra-
tion. Table II summarizes the slopes and intercepts (these
are the weighted averages of from 1 to 4 determinations)
obtained by plotting the relaxation data according to Eq. 3,
as shown in Fig. 5. Since the value of (TlbO,ufd + TbOUfld) for
nicotine is known, these slopes can be used to provide
values for KD/KI (i.e., Knicotine/Kcompeting ligand). These values
are then combined to give the results summarized in Table
III.
The dissociation constants measured here are for the
high affinity, or desensitized state, since the receptors were
at all times saturated with a large excess of ligand. Table
IV lists representative literature values ofKD for acetylcho-
line and carbamycholine (for which the greatest amount of
data are available) for both the low affinity and the high
affinity states of AChR from Torpedo californica. Also
included for comparison are the ratios of Kcarbamycholine/
Kacetylcholine for both states. Both the absolute values and the
ratios of the dissociation constants vary widely from prepa-
ration to preparation, again highlighting the difficulties of
obtaining absolute values.
SUMMARY
The results presented here demonstrate that selective T,
measurements are useful for measuring the competitive
binding of small molecules to the AChR in its desensitized
(high affinity) state. The method exploits the fact that the
magnitude of the selective T1 is very sensitive to the zero
frequency term, and that this term is affected when the
small molecules are temporarily immobilized by binding to
the large AChR/asolectin assemblies. The results show
that the binding constants are in the order acetylcholine >
nicotine > carbamylcholine > muscarine, in agreement
with results from other binding assays. This method works
particularly well when the ligand has fast dissociation
kinetics, which will generally be the case for ligands with
dissociation constants of >10-6 M and higher. This is
recognized as a particularly difficult regime in which to
measure KD by other mthods. (33)
The selective T1 measurements also allow determination
TABLE II
RESULTS FOR NICOTINE TITRATIONS
Competing Slope Intercept
ligand
Nicotine (9.9 ± 0.8) x 10-3 (2.6 + 2.7) x 10-6
Acetylcholine (6.8 ± 0.4) x 10-2 (2.7 ± 0.1) x 10-5
Carbamylcholine (0.18 ± 0.03) x 10-2 (2.23 ± 0.1) x 10-5
Muscarine (0.042 ± 0.004) x 1-2 (2.4 ± 0.1) x 10-5
NICOTINE Ha TI SEL DURING TITRATION
- 0.0005
u)wU'
a 0.0004
-J
0
2 0.0003
'- 0.0002
r0-
' 0.0001
0.0
0.0 0.005 0.010 0.015
COMPETING LIGAND [I] (MOLAR)
0.020
FIGURE 5 Plots of the nicotine HB relaxation data according to Eq. 3 for
competitive titrations with acetylcholine (circles) and for carbamylcho-
line (squares). Error bars were determined by standard methods involv-
ing propagation of errors. (41 )
of the amount of specific binding (i.e., binding to the
acetylcholine site on the receptor) versus nonspecific bind-
ing (i.e., binding to extraneous sites on the receptor and
binding to the lipid vesicles). The results show substantial
interactions of acetylcholine and other ligands with the
lipid vesicles, but a fairly small amount of nonspecific
interactions with the protein.
Because the receptor substrate interaction causes a large
change in the selective relaxation times of the small ligands
even at concentrations of the ligands that are 100 times
greater than the concentration of the receptor binding
sites, this method provides a means of chemical amplifica-
tion; i.e., binding and unbinding of a large amount of
ligand to the small amount of receptor continually pumps
the solution with molecules that have a "memory" of their
bound state. It thereby provides a method to monitor drug
binding when only small amounts of the receptor are
available. In this fashion, it may be possible to use this
method to measure ligand binding to intact cells. It should
be possible to extend this technique to other receptors and
to other similarly "tethered" biological assemblies.
The minimum molecular mechanism of the AChR
involves two states, the low affinity state, and the high
affinity state. (6) Even in the absence of agonist, as much
TABLE III
DISSOCIATION CONSTANT RATIOS
Ka,,rbmyklo1ine 40 ± 7
KacctyIcholinj
Kmuscarne 180 ± 30
Kacetyl.holine
Kmucrne 5 ±1
Ka.rbamy1cholinc
Kacetylchofine 0.14 ± 0.01
Knicotine
K.rba.mylhodi 5.6 ± 0.9
K26±3ine
Kmunrne 26 ± 3
Knicotine
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TABLE IV
LITERATURE DISSOCIATION CONSTANTS (MM) FOR ACETYLCHOLINE RECEPTORS FROM TORPEDO
Preparation Ligand Low affinity High affinity Reference
KD KDcarb/KDacb KD KD.,b/KDab
Electroplax membrane fragments carb 20 0.05 [11]
Membrane fragments 3H-ach 1.0 20 [12]
3H-carb 20.0
Membrane fragments (250C) ach 17,500 0.52 50 2.2 [36]
carb 9,100 110
Triton-solubilized membrane fragments ach 2 0.012 [37]
nic 0.5 0.5
Membrane fragments ach 79.2 10.9 [38]
carb 860
Membrane fragments ach 0.5 60 0.0014 17.9 [39]
carb 30 0.025
Membrane fragments ach 0.003 [40]
as 20% of the receptor is thought to be in the high affinity
state. However, under the conditions used in this work
(large stochiometric excess of acetylcholine or other ago-
nist), essentially all of the receptor is in the high affinity
state. Since this method requires a large excess of agonist,
it would not work well for the low affinity state unless
photolytic (34, 35) or flow methods were worked out to
produce a limited amount of active molecule.
The authors wish to thank Drs. R. Huganir and G. Yee for their expert
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